1. Home
  2. ACRV vs CRWS Comparison

ACRV vs CRWS Comparison

Compare ACRV & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • CRWS
  • Stock Information
  • Founded
  • ACRV 2018
  • CRWS 1957
  • Country
  • ACRV United States
  • CRWS United States
  • Employees
  • ACRV N/A
  • CRWS N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • CRWS Textiles
  • Sector
  • ACRV Health Care
  • CRWS Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • ACRV 36.1M
  • CRWS 34.0M
  • IPO Year
  • ACRV 2022
  • CRWS N/A
  • Fundamental
  • Price
  • ACRV $1.11
  • CRWS $3.26
  • Analyst Decision
  • ACRV Buy
  • CRWS
  • Analyst Count
  • ACRV 7
  • CRWS 0
  • Target Price
  • ACRV $17.60
  • CRWS N/A
  • AVG Volume (30 Days)
  • ACRV 728.6K
  • CRWS 17.1K
  • Earning Date
  • ACRV 05-14-2025
  • CRWS 06-27-2025
  • Dividend Yield
  • ACRV N/A
  • CRWS 9.91%
  • EPS Growth
  • ACRV N/A
  • CRWS N/A
  • EPS
  • ACRV N/A
  • CRWS 0.24
  • Revenue
  • ACRV N/A
  • CRWS $86,602,000.00
  • Revenue This Year
  • ACRV N/A
  • CRWS N/A
  • Revenue Next Year
  • ACRV N/A
  • CRWS N/A
  • P/E Ratio
  • ACRV N/A
  • CRWS $13.70
  • Revenue Growth
  • ACRV N/A
  • CRWS N/A
  • 52 Week Low
  • ACRV $1.05
  • CRWS $2.80
  • 52 Week High
  • ACRV $10.16
  • CRWS $5.35
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 34.87
  • CRWS 53.44
  • Support Level
  • ACRV $1.06
  • CRWS $3.18
  • Resistance Level
  • ACRV $1.19
  • CRWS $3.38
  • Average True Range (ATR)
  • ACRV 0.09
  • CRWS 0.11
  • MACD
  • ACRV 0.05
  • CRWS 0.02
  • Stochastic Oscillator
  • ACRV 21.57
  • CRWS 47.83

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: